WASHINGTON, March 25 (TNSJou) -- The U.S. Department of Energy's Lawrence Berkeley National Laboratory issued the following news release: A research team has uncovered new clues into the exotic behavior of unconventional superconductors - devices that efficiently carry electrical current with zero resistance in ways that defy our previous understanding of physics. "The hope is that our work may lead to a better understanding of superconductivity, which could find applications in next-gen energ  more

WASHINGTON, March 22 -- The Defense Nuclear Facilities Safety Board's Resident Inspector in Los Alamos National Laboratory issued the following weekly report: MEMORANDUM FOR: Christopher J. Roscetti, Technical Director FROM: D. Gutowski and J. Plaue, Resident Inspectors SUBJECT: Los Alamos Activity Report for Week Ending March 4, 2022 DNFSB Staff Activity: A. Hutain was onsite to observe activities by the NNSA team reviewing conduct of operations at the Plutonium Facility. Weapons Engineeri  more

WASHINGTON, March 26 -- Sen. Ben Ray Lujan, D-New Mexico, issued the following news release: U.S. Senator Ben Ray Lujan (D-N.M.) issued the following statement on the confirmation of Alvin Harlyn Warren, of Santa Clara Pueblo, to serve as a Member of the Board of Directors of the Corporation for National and Community Service, the federal agency more commonly known as AmeriCorps: "As the nation's largest grant maker for service and volunteering, AmeriCorps engages millions of Americans in life  more

MINNEAPOLIS, Minnesota, March 26 -- Taft, a law firm, issued the following news: Taft Chicago partners Andrew M. Alul and Roshan P. Shrestha, Ph.D., secured a significant Federal appeals court victory for generic drug client, Bionpharma Inc. ("Bionpharma"). Bionpharma markets a 1.0 mg/mL enalapril maleate oral solution as generic to Azurity Pharmaceuticals, Inc.'s ("Azurity," formerly Silvergate Pharmaceuticals, Inc.) Epaned(R), a prescription drug product used to treat hypertension in children  more